Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Dermatol Surg ; 49(12): 1072-1076, 2023 12 01.
Article in English | MEDLINE | ID: mdl-37962150

ABSTRACT

BACKGROUND: According to the curriculum guidelines of the Accreditation Council of Graduate Medical Education and the American Board of Dermatology, Mohs micrographic surgery & dermatologic oncology (MSDO) fellows must demonstrate competency in the use of oral skin cancer chemoprophylaxis. The current level of education in this area is unknown. OBJECTIVE: To characterize oral skin cancer chemoprophylaxis education for acitretin and nicotinamide among current MSDO fellows and to compare the clinical indications felt most appropriate for prescribing to a previously published expert consensus. METHODS: An electronic survey was distributed to all active MSDO fellows by the American College of Mohs Surgery. RESULTS: Responses were received from 63 (69.2%) MSDO fellows. Twenty (31.7%) and 37 (58.7%) fellows reported receiving fellowship training on acitretin and nicotinamide, respectively. Fifty-seven (90.5%) intend to prescribe chemoprophylaxis after training. Sixteen (28.1%) and 43 (75.4%) report feeling very comfortable prescribing acitretin and nicotinamide, respectively. Fellow concordance with a previously published expert consensus opinion on appropriate prescribing indications is variable. Forty-one (65.1%) indicated that additional education would increase the likelihood to prescribe after training. CONCLUSION: Although most MSDO fellows intend to prescribe oral skin cancer chemoprophylaxis, a standardized curriculum may promote increased use and concordance with expert consensus recommendations.


Subject(s)
Mouth Neoplasms , Skin Neoplasms , Humans , United States , Mohs Surgery/education , Cross-Sectional Studies , Acitretin/therapeutic use , Skin Neoplasms/prevention & control , Skin Neoplasms/surgery , Curriculum , Educational Status , Education, Medical, Graduate , Niacinamide , Fellowships and Scholarships , Surveys and Questionnaires
2.
Rep Pract Oncol Radiother ; 27(3): 387-391, 2022.
Article in English | MEDLINE | ID: mdl-36186697

ABSTRACT

Background: COVID-19 has significantly impacted cancer care. While previous studies have emphasized treatment modification and prioritized the delivery of cancer care, few have examined this issue from the public perspective. Materials and methods: In the following study, we examine how public interest in various forms of cancer treatment has evolved during the pandemic using Google Trends. One-way ANOVA and linear regression tests were used to compare the mean search volume indices of three periods: pre-lockdown, lockdown, and reopening. Results/Conclusions: Our findings suggest that public interest in cancer treatments decreased during lockdown and returned after reopening but, in general, is still lower than pre-lockdown levels. Despite that, healthcare professionals should strive to provide timely cancer care, assuage patients' fears of healthcare settings, and encourage patients to continue proper cancer screenings.

4.
Dermatol Surg ; 47(10): 1333-1336, 2021 10 01.
Article in English | MEDLINE | ID: mdl-34537788

ABSTRACT

BACKGROUND: Desmoplastic melanoma (DM) is a rare variant of cutaneous melanoma with a high rate of local recurrence. Recent studies have indicated a potential benefit in local control with the addition of adjuvant radiotherapy (RT). OBJECTIVE: This study sought to evaluate the outcomes of adjuvant RT for patients with DM. MATERIALS AND METHODS: The National Cancer Database was queried (2004-2015) for patients with newly diagnosed, nonmetastatic DM. Patients were divided into 2 groups based on the adjuvant therapy they received: RT or observation. Statistics included multivariable logistic regression to determine factors predictive of receiving adjuvant RT, Kaplan-Meier analysis to evaluate overall survival (OS), and Cox proportional hazards modeling to determine variables associated with OS. RESULTS: There was no difference in median OS between patients treated with RT when compared with patients observed (111.4 months vs 133.9 months, p = .1312). On multivariable analysis, older age, T stage ≥2, N stage ≥1, and no receipt of immunotherapy were associated with worse OS. CONCLUSION: In this large study evaluating efficacy of adjuvant RT in DM, no overall survival benefit was observed among patients receiving adjuvant RT.


Subject(s)
Dermatologic Surgical Procedures/statistics & numerical data , Melanoma/therapy , Radiotherapy, Adjuvant/statistics & numerical data , Skin Neoplasms/therapy , Aged , Aged, 80 and over , Humans , Immunotherapy/statistics & numerical data , Kaplan-Meier Estimate , Margins of Excision , Melanoma/mortality , Middle Aged , Retrospective Studies , Skin Neoplasms/mortality , Treatment Outcome
5.
J Drugs Dermatol ; 20(8): 905-906, 2021 Aug 01.
Article in English | MEDLINE | ID: mdl-34397191

ABSTRACT

Based on surveys by Robinson1 in 2001 and Trimble and Cherpeli2 in 2013, Immunohistochemistry (IHC) utilization in Mohs micrographic surgery (MMS) has been rising. Although these surveys provided important subjective data regarding IHC use in MMS, there is a paucity of objective data describing its current utilization patterns. The objective of this study is to characterize IHC utilization during MMS by Mohs surgeons in the treatment of Medicare beneficiaries from 2012-2017.


Subject(s)
Surgeons , Aged , Humans , Immunohistochemistry , Medicare , Mohs Surgery , Skin Neoplasms/surgery , United States
6.
J Am Acad Dermatol ; 82(2): 303-310, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31542405

ABSTRACT

BACKGROUND: The predictors of readmission in Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) have not been characterized. OBJECTIVE: To determine the variables predictive of 30-day readmission after SJS/TEN hospitalization. METHODS: We performed a cross-sectional study of the 2010-2014 Nationwide Readmissions Database. Bivariate and multivariable logistic regression was used to evaluate associations of patient demographics, comorbidities, and hospital characteristics with readmission. Aggregate and per-readmission costs were calculated. RESULTS: There were 8837 index admissions with SJS/TEN reported; of these, 910 (10.3%) were readmitted, with diagnoses including systemic infection (22.0%), SJS/TEN (20.6%), and cutaneous infection (9.1%). Associated characteristics included age 45 to 64 years (odds ratio [OR], 1.88; 95% confidence interval [CI], 1.43-2.49), Medicaid insurance (OR, 1.83; 95% CI, 1.48-2.27), and nonmetropolitan hospital admission (OR, 1.67; 95% CI, 1.31-2.13). Associated comorbidities included HIV/AIDS (OR, 2.48; 95% CI, 1.63-3.75), collagen vascular disease (OR, 2.38; 95% CI, 1.88-3.00), and metastatic cancer (OR, 2.16; 95% CI, 1.35-3.46). The median per-readmission cost was $10,019 (interquartile range, $4,788-$16,485). LIMITATIONS: The Nationwide Readmissions Database lacks the ability to track the same patient across calendar years. The diagnostic code lacks specificity for hospitalizations <3 days. CONCLUSIONS: Thirty-day readmissions after SJS/TEN hospitalizations are common. Dedicated efforts to identify at-risk patients may improve peridischarge continuity.


Subject(s)
Patient Readmission/statistics & numerical data , Stevens-Johnson Syndrome/epidemiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Child , Child, Preschool , Comorbidity , Continuity of Patient Care/organization & administration , Cross-Sectional Studies , Databases, Factual , Female , HIV Infections/epidemiology , Hospital Costs/statistics & numerical data , Humans , Infant , Infant, Newborn , Male , Middle Aged , Neoplasms/epidemiology , Neoplasms/pathology , Patient Readmission/economics , Risk Assessment/statistics & numerical data , Risk Factors , Stevens-Johnson Syndrome/diagnosis , Stevens-Johnson Syndrome/economics , Stevens-Johnson Syndrome/therapy , United States/epidemiology , Vascular Diseases/epidemiology , Young Adult
7.
Dermatol Surg ; 46(4): 546-553, 2020 04.
Article in English | MEDLINE | ID: mdl-31584528

ABSTRACT

BACKGROUND: The V-Y island advancement flap is a useful reconstruction technique for nasal alar defects, but flap mobility is limited by the insertion of the muscles of facial expression into the dermis of the alae. OBJECTIVE: To describe a V-Y muscle sling myocutaneous island advancement flap (SMIAF) for improved mobility and intrasubunit reconstruction of alar defects. MATERIALS AND METHODS: A retrospective review of patient records and preoperative and postoperative photographs was performed on all patients with alar defects repaired with the SMIAF between April 2008 and October 2017. Patients and physicians rated aesthetic outcomes with the Patient and Observer Scar Assessment Scale (POSAS). RESULTS: A total of 18 nasal alar defects were repaired with the SMIAF after Mohs micrographic surgery. All defects were located on the anterior two-thirds of the alar lobule and had a mean surface area of 0.42 ± 0.19 cm. No patients experienced flap necrosis. Patients and 3 independent dermatologic surgeons rated favorable aesthetic outcomes. CONCLUSION: The SMIAF is a reliable reconstruction option with good aesthetic outcomes for small defects on the anterior two-thirds of the nasal ala.


Subject(s)
Cicatrix/prevention & control , Mohs Surgery/adverse effects , Myocutaneous Flap/transplantation , Nose Neoplasms/surgery , Rhinoplasty/methods , Skin Neoplasms/surgery , Adult , Aged , Cicatrix/diagnosis , Cicatrix/etiology , Esthetics , Female , Humans , Male , Middle Aged , Myocutaneous Flap/pathology , Necrosis/epidemiology , Necrosis/etiology , Nose/anatomy & histology , Nose/pathology , Nose/surgery , Patient Reported Outcome Measures , Reproducibility of Results , Retrospective Studies , Treatment Outcome
8.
Pediatr Dermatol ; 37(5): 985-986, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32729151

ABSTRACT

Demodex spp. mites are a common colonizer of sebaceous adult skin. Though usually clinically insignificant, demodicosis may be associated with a wide spectrum of skin diseases in immunocompetent hosts, such as erythematotelangiectatic and papulopustular rosacea, Demodex folliculorum, and blepharitis. We present a case of a healthy 9-year-old boy with an exuberant, inflammatory, Demodex-associated pustular eruption of the face, induced by the use of a high-potency topical steroid and successfully treated with oral ivermectin.


Subject(s)
Steroids/therapeutic use , Animals , Blepharitis , Child , Humans , Male , Mite Infestations/diagnosis , Mite Infestations/drug therapy , Mites , Rosacea/diagnosis , Rosacea/drug therapy
9.
Pediatr Radiol ; 49(3): 342-350, 2019 03.
Article in English | MEDLINE | ID: mdl-30506328

ABSTRACT

BACKGROUND: Patients who have undergone the Fontan operation for palliation of congenital heart disease with single-ventricle pathophysiology are at high risk for developing progressive liver fibrosis. Pathological assessment from percutaneous liver biopsy is central to the management of Fontan-associated liver disease, but liver biopsy in this vulnerable population poses unique challenges and potential risks. OBJECTIVE: This retrospective study describes our experience with percutaneous liver biopsy performed to assess changes of Fontan-associated liver disease, with particular regard to procedural outcomes. MATERIALS AND METHODS: Data from liver biopsy procedure reports, pathology reports, cardiac angiography pressure measurements and laboratory values of patients with single ventricle heart disease after the Fontan operation who underwent ultrasound-guided percutaneous liver biopsy performed in interventional radiology at a pediatric tertiary care center during a 3-year period were retrospectively analyzed. RESULTS: Sixty-eight liver biopsies were performed in 67 patients (mean age: 20.2 years, range: 7.2-39 years). The technical success rate was 100%, and tissue was adequate for assessing liver disease in 100% of the procedures, including biopsies performed with a single pass. Anticoagulation was routinely suspended before biopsy, and no cardiac complications were encountered due to this suspension. A coaxial biopsy system using an 18-gauge (G) full-core instrument through a 17-G introducer trocar was most commonly used, in 41/68 cases (60%). The most common trough length was 2.3 cm, used in 37 cases (54%). One pass was made in 27 procedures (40%) and two passes in 30 (44%); tract embolization with gelatin sponge was performed in 52 (76%). The only complication was hemorrhage, which occurred in 5/68 (7.4%) of the biopsies, minor in four (5.9%) and major in one (1.5%) -- similar to rates reported for liver biopsy in non-Fontan patients. Hemorrhage had a delayed presentation in three of these five cases. Immediate post-biopsy hemoglobin decrease of ≥2 mg/dL showed a low sensitivity for hemorrhage. The mean Fontan pressure measured during cardiac angiography was 13.8 mmHg, and shunt pressures were not associated with an increased risk of hemorrhage. CONCLUSION: Percutaneous liver biopsy in Fontan patients can be performed safely with high technical success rates and without increased complication rates. Meticulous technique and close observation are recommended to reduce post-biopsy complications. The degree of right heart pressure elevation was not associated with hemorrhage.


Subject(s)
Fontan Procedure , Image-Guided Biopsy , Liver Cirrhosis/pathology , Ultrasonography, Interventional , Adolescent , Adult , Biopsy, Needle , Child , Female , Humans , Male , Retrospective Studies
16.
Pediatr Radiol ; 46(4): 534-40, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26795617

ABSTRACT

BACKGROUND: Inferior vena cava (IVC) filters are commonly implanted with the intent to prevent life-threatening pulmonary embolism in at-risk patients with contraindications to anticoagulation. Various studies have reported increases in the rate of venous thromboembolism within the pediatric population. The utility and safety of IVC filters in children has not yet been fully defined. OBJECTIVE: To describe the technique and adjunctive maneuvers of IVC filter removal in children, demonstrate its technical success and identify complications. MATERIALS AND METHODS: A retrospective 10-year review was performed of 20 children (13 male, 7 female), mean age: 15.1 years (range: 12-19 years), who underwent IVC filter retrieval. Eleven of 20 (55%) were placed in our institution. Electronic medical records were reviewed for filter characteristics, retrieval technique, technical success and complications. RESULTS: The technical success rate was 100%. Placement indications included: deep venous thrombosis with a contraindication to anticoagulation (10/20, 50%), free-floating thrombus (4/20, 20%), post-trauma pulmonary embolism prophylaxis (3/20, 15%) and pre-thrombolysis pulmonary patient (1/20, 5%). The mean implantation period was 63 days (range: 20-270 days). Standard retrieval was performed in 17/20 patients (85%). Adjunctive techniques were performed in 3/20 patients (15%) and included the double-snare technique, balloon assistance and endobronchial forceps retrieval. Median procedure time was 60 min (range: 45-240 min). Pre-retrieval cavogram demonstrated filter tilt in 5/20 patients (25%) with a mean angle of 17° (range: 8-40). Pre-retrieval CT demonstrated strut wall penetration and tip embedment in one patient each. There were two procedure-related complications: IVC mural dissection noted on venography in one patient and snare catheter fracture requiring retrieval in one patient. There were no early or late complications. CONCLUSION: In children, IVC filter retrieval can be performed safely but may be challenging, especially in cases of filter tilt or embedding. Adjunctive techniques may increase filter retrieval rates.


Subject(s)
Device Removal/statistics & numerical data , Postoperative Complications/epidemiology , Pulmonary Embolism/epidemiology , Pulmonary Embolism/prevention & control , Vena Cava Filters/statistics & numerical data , Venous Thromboembolism/epidemiology , Adolescent , Causality , Child , Comorbidity , Device Removal/methods , Female , Hospitals, Pediatric/statistics & numerical data , Humans , Incidence , Male , Philadelphia/epidemiology , Postoperative Complications/prevention & control , Retrospective Studies , Risk Factors , Tertiary Care Centers/statistics & numerical data , Venous Thromboembolism/prevention & control , Young Adult
20.
Dermatol Clin ; 41(1): 1-11, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36410970

ABSTRACT

The rising incidence of cutaneous squamous cell carcinoma (cSCC) represents a public health crisis. Although most cases of cSCC are cured with surgical excision alone, high-risk disease requires a coordinated strategy involving accurate staging, possible multimodal therapy, and clinical and radiologic surveillance. In the following review, we present an evidence-based update on the current paradigm of diagnosis and management of cSCC and discuss the most relevant areas of active research related to prognostic staging as well as the appropriate use of radiologic imaging and adjuvant therapy.


Subject(s)
Carcinoma, Squamous Cell , Skin Neoplasms , Humans , Carcinoma, Squamous Cell/diagnostic imaging , Carcinoma, Squamous Cell/surgery , Skin Neoplasms/diagnostic imaging , Skin Neoplasms/surgery , Neoplasm Staging , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL